We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

FDA Clears Antibiotic-Delivering Spacer for Infected Knee Replacements

By HospiMedica International staff writers
Posted on 09 Oct 2026

Periprosthetic joint infection develops around an artificial joint implant and can be especially difficult to manage after knee replacement. More...

Treatment may require removal of the implant, prolonged infection control, and later reconstruction, while temporary joint support and local antibiotic delivery must be maintained in the interim. A newly cleared device is designed to address these needs by combining antibiotic delivery with load-bearing support.

Mass General Brigham (Boston, MA, USA) researchers have developed a temporary knee spacer that has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The device is intended for patients who develop infection around an artificial knee implant. After the infected implant is removed, the spacer maintains the joint space and provides structural support until a new artificial joint can be placed.

The spacer incorporates gentamicin into ultra-high-molecular-weight polyethylene, or UHMWPE. This medical-grade plastic is a durable, wear-resistant polymer that is commonly used in artificial joints. By embedding the antibiotic into UHMWPE, the device is designed to release gentamicin directly into the infected joint while preserving the mechanical strength needed to support the patient during treatment.

Infection occurs after approximately 2% of knee replacement surgeries. Standard treatment typically involves multiple operations and placement of a temporary spacer made from antibiotic-loaded bone cement. These cement spacers may provide limited support and may release antibiotics inconsistently, creating a need for more predictable structural and antimicrobial performance.

The technology grew out of research at the Harris Orthopaedics Laboratory. In a 2025 study published in The Journal of Bone & Joint Surgery, investigators reported that very small gentamicin particles produced higher and more sustained antibiotic release. The same approach preserved more than 90% of the polymer’s original mechanical strength.

Mass General Brigham Innovation helped advance the technology from laboratory research toward commercialization. The organization secured patent protection and worked with industry partners with product-development and market expertise. It is also in the process of licensing the intellectual property rights to a large implant manufacturer.

“Our goal was to create a spacer that can deliver antibiotics directly to the affected joint while remaining strong enough to support patients during treatment. This clearance is an important step toward making that technology available for patient care,” said Orhun K. Muratoglu, PhD, director of the Harris Orthopaedics Laboratory and vice chair of clinical innovation in the Department of Orthopedic Surgery at Mass General Brigham.

Related Links
Mass General Brigham


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Wound Irrigation Solution
Prontosan®
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image Credit: Shutterstock

Explainable AI Examines Sepsis Mortality Risk and Emergency Care Delays

Preventing sepsis-related deaths in emergency departments (EDs) remains challenging because patient deterioration can result from multiple rapidly evolving and interconnected factors. These include triage... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image: A new automated approach could help predict which patients with dystonia will benefit from deep brain stimulation before surgery (Image Credit: Adobe Stock)

AI Uses Routine MRI to Predict Deep Brain Stimulation Response in Dystonia

Dystonia is a debilitating neurological movement disorder characterized by involuntary muscle contractions that cause abnormal movements and postures. Deep brain stimulation (DBS) is one of the few treatments... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.